Nanostics has secured funding from Genome Canada and Genome Alberta to expedite the ClarityDX Prostate test integration into ...

Prostatitis, or inflammation of the prostate, is more common than you might think — it accounts for roughly two million ...

the inflammation of the prostate. It can cause unpleasant urination, either acute or chronic pelvic pain, and discomfort ...

We used SEER-Medicare data for patients 66 years and older with de novo metastatic prostate cancer who were prescribed abiraterone, enzalutamide, or apalutamide from 2010 to 2017. Negative binomial ...

Nanostics Inc., a precision health company developing diagnostic tests with its ClarityDX® platform technology, announced today significant financial support from Genome Canada and Genome Alberta ...

American Oncology Institute (AOI) at Citizens Specialty Hospital, Hyderabad, has successfully managed a complex and rare case ...

Staff and patients at two mental health hospitals in Bradford participated in a charity walk to raise awareness and ...

Two patients in Dak Lak have tested positive for the deadly “flesh-eating” Whitmore disease. Local health authorities are now ...

American Oncology Institute (AOI) at Citizens Specialty Hospital, Hyderabad, has successfully managed a complex and rare case of advanced-stage prostate cancer with transformation in a 72-year-old ...

Funding to Propel Widespread Adoption and Integration of Innovative Prostate Cancer Diagnostic Test into Canadian Healthcare EDMONTON, AB, June 26, 2025 /PRNewswire/ - Nanostics Inc., a precision ...

Leading Edge Health has released a 2025 update to its PrimeGENIX Prostate Support supplement, spotlighting clean-label ...